Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,293 | -8,474 | -16,919 | -10,599 | -3,638 |
| Depreciation Amortization | 0 | 0 | 5 | 4 | 3 |
| Accounts payable and accrued liabilities | 569 | 1,436 | -106 | 30 | 960 |
| Other Working Capital | -593 | 915 | 76 | -8 | -77 |
| Other Operating Activity | 2,029 | -247 | 4,457 | 2,587 | -105 |
| Operating Cash Flow | $-12,288 | $-6,369 | $-12,486 | $-7,985 | $-2,856 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 30 | 8 | 48,889 | 48,889 | 48,766 |
| Financing Cash Flow | $30 | $8 | $48,889 | $48,889 | $48,766 |
| Beginning Cash Position | 65,243 | 65,243 | 28,840 | 28,840 | 28,840 |
| End Cash Position | 52,985 | 58,881 | 65,243 | 69,744 | 74,749 |
| Net Cash Flow | $-12,258 | $-6,362 | $36,403 | $40,904 | $45,910 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,288 | -6,369 | -12,486 | -7,985 | -2,856 |
| Free Cash Flow | -12,288 | -6,369 | -12,486 | -7,985 | -2,856 |